cardiology

News in brief: GLP-1 RA cardiovascular benefits from visceral fat loss; Doctor wins $450k damages for malicious reviews; Vitamin K-rich  diet may reduce atherosclerotic cardiovascular disease

GLP-1 RA cardiovascular benefits from visceral fat loss The GLP-1 receptor agonist liraglutide may help achieve weight loss with cardiovascular benefits through selective loss of  visceral fat, a US study shows. In a 40 week study in 128 adults with overweight and obesity at high cardiovascular disease risk,  a once-daily dose of 3mg liraglutide resulted ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic